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Cholesterol is one of the major lipid components of the
plasma membrane of mammalian cells. This lipid, with its
fused ring structure, has very different physical properties
from the phospholipid and sphingolipid components of the
cell membrane. There has been a long interest in the role of
cholesterol in determining the physical properties of a
membrane and affecting biological functions. In recent years
there has been a resurgence of interest in the physical
properties of cholesterol and its relationship to biological
function. Much of this interest has been focused on the
question of the presence of cholesterol-rich domains in
biological membranes that have particular biological func-
tions [1]. In this issue several specific biological function that
are related to the presence of cholesterol-rich domains are
discussed. These functions are discussed along with reviews
of our current understanding of the nature of cholesterol
interactions with other membrane lipid components.
In order to understand the molecular properties of choles-
terol in membranes, one has to begin with simpler mixtures
than those of biological membranes. In relation to the
formation of cholesterol-rich domains, the miscibility of
cholesterol with other lipids is of particular relevance. This
topic has been studied for many years. Cholesterol has long
been known to restrict the motional properties of phospho-
lipids in membrane. More recently, this has led to a descrip-
tion of a new phase, the liquid ordered phase, which has the
properties of both the solid and liquid phase. The acyl chains
are extended, with largely trans rotamers in the hydrocarbon
chain, as in the solid phase. In addition, however, the rate of
lateral diffusion is rapid and mimics that of the liquid phase.
In addition to the effects of cholesterol on the bulk physical
properties of the membrane, it has also been proposed that
cholesterol forms specific complexes with phospholipids.
The article in this issue by McConnell and Radhakrishnan
makes a case, based on a consideration of the phase behavior
and miscibility in monolayers, for the formation of con-
densed complexes of cholesterol and phospholipids having
specific stoichiometries.
Silvius discusses the effect of phospholipid structure, both
the headgroup as well as the degree of unsaturation of the
hydrocarbon portion. They also review the evidence for the
formation of cholesterol-rich domains in model membranes.
It is not surprising that cholesterol and phospholipids are
not miscible in all proportions, with the two lipids being so
different structurally as well as having different polarities. As
a consequence, when cholesterol passes a certain mole
fraction it forms crystallites that can be detected by calorim-
etry, diffraction and MAS NMR. Bach and Wachtel discuss
the application of these methods in detecting cholesterol
crystals. The dramatically lower solubility of cholesterol
monohydrate crystals in bilayers of phosphatidylserine com-
pared with phosphatidylcholine has recently been demon-
strated byMASNMR [2]. This may have particular relevance
for the arrangement of cholesterol on the cytoplasmic face of
cholesterol-rich domains in plasma membranes. A detailed
understanding of the physical basis of this phenomenon is
lacking. The biological relevance of the formation of crys-
talline domains is discussed by Mason, Tulenko and Jacob.
They particularly focus on the plasma membranes from
arterial smooth muscle cells and from ocular lens fiber cells.
They present diffraction evidence that the cholesterol crys-
tallites are part of the membrane bilayer and not as physically
separate crystals. It is also suggested that the cholesterol
crystallites of arterial smooth muscle cells may play a role in
atherosclerosis, while in the case of the ocular lens fiber cells,
they may be essential for the normal physiology. The phe-
nomenon of the formation of ordered, crystalline-like
domains of cholesterol in biological specimens is also dis-
cussed by Addadi, Geva and Kruth using recognition by
cholesterol antibodies as the criterion for the presence of
ordered cholesterol domains. Some of these cholesterol anti-
bodies have been shown to interact with crystals of choles-
terol monohydrate but not with monomeric cholesterol. Some
of the antibody labeling patterns are responsive to agents or
mutations that effect cholesterol trafficking.
Cholesterol is the only major lipid component in mammals
that is not oxidized as a source of energy. A large fraction of
the cholesterol in the body, apart from the liver, is delivered
and removed by circulating lipoprotein particles. The rela-
tionship of this cholesterol traffic to the formation and
stability of cholesterol-rich domains in membranes is out-
lined by the Fieldings. In their review, the composition and
properties of the two types of cholesterol-rich domains, rafts
and caveolae, are discussed. They suggest that changes in free
cholesterol, through cholesterol trafficking processes, can
modulate signal transduction processes by modulating the
formation of protein complexes in cholesterol-rich domains.
There is considerable evidence for the formation of
cholesterol-rich domains in model membranes and of cho-
lesterol-rich invaginations in regions of cell plasma mem-
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branes also containing caveolin, i.e. caveolae. However, the
characteristics of the putative ‘‘floating’’ rafts, or even their
very existence in biological membranes, are less well
defined. Subczynski and Kusumi review the applications
of pulse EPR spin labeling and single molecule fluorescence
tracking techniques for the study of the size, lifetime and
dynamics of rafts in both model and biological membranes.
They indicate the heterogeneity of the size and lifetime of
rafts in biological membranes. One of the concepts that
these authors emphasize is that the sequestration into raft
domains is not all or none, but rather a preferential parti-
tioning of certain molecules toward one environment com-
pared with another. In the small volume of a membrane, the
relative affinity for one phase over another does not have to
be very high to result in an increased concentration of a
component in a particular domain.
One of the functions of rafts that have been suggested in
several contexts is its role in signal transduction. There has
been speculation about the physical environment of choles-
terol-rich domains modulating the activity of proteins as
well as the role of ‘‘rafts’’ in recruiting proteins into a
specific location in the plasma membrane where they will
interact with each other in a more efficient manner. This
latter mechanism has been extensively described with regard
to signaling in lymphocytes [3–5]. The role of rafts in
concentrating specific proteins into a smaller domain is
described by Bodin, Tronche`re and Payrastre for signal
transduction in platelets. These domains also contain spe-
cific lipids required for signal transduction and the concen-
tration of these molecules into a domain will lead to an
efficient and coordinated activation mechanism.
The largest pool of cholesterol in the body, as well as the
highest concentration of cholesterol in any tissue, is in the
brain [6,7]. There is growing evidence to suggest that lipid
rafts play an important role in neuronal signaling as well as
in neuronal cell adhesion, axon guidance and synaptic
transmission [8]. Evidence from the fraction of the mem-
brane that is insoluble in Triton suggests that brain rafts
differ in both lipid and protein composition, compared with
the detergent-insoluble fraction of other cells. There is less
sphingomyelin in the raft fraction from brains, compared
with other cells. One of the proteins of rafts is NAP-22, a
22-kDa acidic protein that is myristoylated at the amino
terminus. This protein has the unusual property of binding
to liposomes containing a high mole fraction of cholesterol
but not to liposomes composed only of phosphatidylcholine
[9]. Maekawa discusses the properties of this protein and
other proteins of brain rafts. NAP-22 shares a unique role
with another raft protein, GAP-43, in neurite outgrowth and
anatomical plasticity [10]. Another observation indicating
the importance of cholesterol for brain development is that
glia-derived cholesterol is required for synaptogenesis. The
role of cholesterol in the development and stability of
synapse is discussed by Pfrieger. There is also a role for
cholesterol in the brain pathology accompanying Alzheim-
er’s disease. There is evidence that cholesterol-lowering
drugs reduce the risk of Alzheimer’s disease. The relation-
ship of cholesterol to the disease appears to be the result of
the role of this lipid in the interaction of the amyloid h-
peptide with membranes. Wood and colleagues discuss the
relationship between the amount and distribution of choles-
terol in the brain and the accumulation and synthesis of the
amyloid h-peptide.
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